医疗服务提供者对肺栓塞评估中使用循证风险分层工具的看法:一项定性研究
该定性研究对来自4个医院系统的23名提供者进行半结构化访谈,基于实施科学框架(CFIR和TDF)识别肺栓塞循证诊断检测采纳的障碍与促进因素。障碍主要在提供者层面:对工具缺乏知识(尤其对Wells评分验证系统误解)、风险回避和追求确定性;既往实施策略的障碍包括认为临床决策支持(CDS)工具增加步骤且价值低,多数参与者报告因已做出决定而覆盖CDS干预。所有提供者均将机构层面策略视为促进因素,包括背书指南、关于影像阳性率的审计反馈与同行比较、同行压力。作者结论认为未来促进肺栓塞循证诊断的努力应参考这些决定因素。
要点
- 障碍主要在提供者层面:对风险分层工具缺乏知识,尤其对Wells评分验证系统存在误解。
- 风险回避和对确定性的需求是提供者层面使用循证诊断工具的主要障碍。
- 多数参与者报告因已做出决定而覆盖肺栓塞CDS干预,认为其增加步骤且价值低。
- 所有提供者均将机构层面策略视为促进因素:背书指南、影像阳性率审计反馈与同行比较、同行压力。
- 作者认为未来促进肺栓塞循证诊断的努力应参考这些决定因素。
适用人群与场景
- 来自4个医院系统的23名提供者,执业年限和执业环境多样。
研究设计与关键结果
- 定性研究:对来自4个医院系统的23名提供者进行半结构化访谈,基于实施科学框架(CFIR和TDF)开发访谈指南。
- 障碍主要在提供者层面:对工具缺乏知识(尤其对Wells评分验证系统误解)、风险回避、追求确定性。
- 既往实施策略的障碍:认为肺栓塞CDS工具增加步骤且价值低;多数参与者报告因已做出决定而覆盖CDS干预。
- 所有提供者均将机构层面策略视为促进因素:背书指南、关于影像阳性率的审计反馈与同行比较、同行压力。
- 作者结论:未来促进肺栓塞循证诊断的努力应参考这些决定因素。
证据类型、等级与局限
- 证据类型:定性研究(半结构化访谈)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来促进肺栓塞循证诊断的努力应参考这些决定因素(提供者层面障碍与机构层面促进因素)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Providers often pursue imaging in patients at low risk of pulmonary embolism (PE), resulting in imaging yields <10% and false-positive imaging rates of 10% to 25%. Attempts to curb overtesting have had only modest success and no interventions have used implementation science frameworks. The objective of this study was to identify barriers and facilitators to the adoption of evidence-based diagnostic testing for PE.
METHODS: We conducted semistructured interviews with a purposeful sample of providers. An interview guide was developed using the implementation science frameworks, consolidated framework for implementation research, and theoretical domains framework. Interviews were recorded, transcribed, and analyzed in an iterative process. Emergent themes were identified, discussed, and organized.
RESULTS: We interviewed 23 providers from four hospital systems, and participants were diverse with regard to years in practice and practice setting. Barriers were predominately at the provider level and included lack of knowledge of the tools, particularly misunderstanding of the validated scoring systems in Wells, as well as risk avoidance and need for certainty. Barriers to prior implementation strategies included the perception of a clinical decision support (CDS) tool for PE as adding steps with little value; most participants reported that they overrode CDS interventions because they had already made the decision. All providers identified institution-level strategies as facilitators to use, including endorsed guidelines, audit feedback with peer comparison about imaging yield, and peer pressure.
CONCLUSIONS: This exploration of the use of risk stratification tools in the evaluation of PE found that barriers to use primarily exist at the provider level, whereas facilitators to the use of these tools are largely perceived at the level of the institution. Future efforts to promote the evidence-based diagnosis of PE should be informed by these determinants.
参考来源
- Westafer LM, Kunz A, Bugajska P, et al. Provider Perspectives on the Use of Evidence-based Risk Stratification Tools in the Evaluation of Pulmonary Embolism: A Qualitative Study. Acad Emerg Med. 2020. PMID: 32220127. doi:10.1111/acem.13908
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。